FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3039269780> ?p ?o ?g. }

• W3039269780 endingPage "32" @default.
• W3039269780 startingPage "27" @default.
• W3039269780 abstract "It is unclear if patients with paroxysmal atrial fibrillation (AF) and persistent AF have different outcomes following electrical cardioversion (ECV). ENSURE-AF—a multicenter, prospective, randomized, open-label, blinded-endpoint evaluation trial—compared once-daily edoxaban 60 mg with enoxaparin–warfarin in 2,199 subjects undergoing ECV of nonvalvular AF (NCT02072434). Patients received ≥3 weeks of proper anticoagulation or transesophageal echocardiogram before ECV paroxysmal AF was defined as AF with spontaneous conversion of duration of <7 days; persistent AF was defined as AF lasting ≥7 days without spontaneous conversion. Clinical characteristics and outcomes were compared between subjects based on type of AF present at baseline. In total, 415 subjects had paroxysmal AF; 1,777 had persistent AF. Patients with paroxysmal AF were older (65.8 ± 10.3 vs 63.9 ± 10.5, p = 0.001) with more hypertension (82.7% vs 77.2%, p = 0.01) versus persistent AF patients. Congestive heart failure was more common in persistent AF (46.7%) versus paroxysmal AF (31.3%, p <0.0001). CHA2DS2-VASc (score >2: 52.0% vs 49.5%, p = 0.4375) and prior myocardial infarction (6.5% vs 6.8%, p = 0.91) did not significantly differ between groups. After ECV, primary endpoint events were numerically higher in paroxysmal AF versus persistent AF (1.5% vs 0.6%, p = 0.0571), approaching statistical significance. Of note, myocardial infarction was observed in paroxysmal AF (n = 4 vs 0), whereas persistent AF was accompanied by stroke (n = 0 vs 5; p <0.05). In conclusion, patients with paroxysmal AF had more frequent major cardiovascular events than patients with persistent AF. Composite event rates were driven mainly by myocardial infarction in patients with paroxysmal AF and by stroke in those with persistent AF. Overall, the absolute number of events was low after ECV under anticoagulation. It is unclear if patients with paroxysmal atrial fibrillation (AF) and persistent AF have different outcomes following electrical cardioversion (ECV). ENSURE-AF—a multicenter, prospective, randomized, open-label, blinded-endpoint evaluation trial—compared once-daily edoxaban 60 mg with enoxaparin–warfarin in 2,199 subjects undergoing ECV of nonvalvular AF (NCT02072434). Patients received ≥3 weeks of proper anticoagulation or transesophageal echocardiogram before ECV paroxysmal AF was defined as AF with spontaneous conversion of duration of <7 days; persistent AF was defined as AF lasting ≥7 days without spontaneous conversion. Clinical characteristics and outcomes were compared between subjects based on type of AF present at baseline. In total, 415 subjects had paroxysmal AF; 1,777 had persistent AF. Patients with paroxysmal AF were older (65.8 ± 10.3 vs 63.9 ± 10.5, p = 0.001) with more hypertension (82.7% vs 77.2%, p = 0.01) versus persistent AF patients. Congestive heart failure was more common in persistent AF (46.7%) versus paroxysmal AF (31.3%, p <0.0001). CHA2DS2-VASc (score >2: 52.0% vs 49.5%, p = 0.4375) and prior myocardial infarction (6.5% vs 6.8%, p = 0.91) did not significantly differ between groups. After ECV, primary endpoint events were numerically higher in paroxysmal AF versus persistent AF (1.5% vs 0.6%, p = 0.0571), approaching statistical significance. Of note, myocardial infarction was observed in paroxysmal AF (n = 4 vs 0), whereas persistent AF was accompanied by stroke (n = 0 vs 5; p <0.05). In conclusion, patients with paroxysmal AF had more frequent major cardiovascular events than patients with persistent AF. Composite event rates were driven mainly by myocardial infarction in patients with paroxysmal AF and by stroke in those with persistent AF. Overall, the absolute number of events was low after ECV under anticoagulation." @default.
• W3039269780 created "2020-07-10" @default.
• W3039269780 creator A5011073019 @default.
• W3039269780 creator A5019955596 @default.
• W3039269780 creator A5029533765 @default.
• W3039269780 creator A5033166833 @default.
• W3039269780 creator A5038405190 @default.
• W3039269780 creator A5070415714 @default.
• W3039269780 creator A5082164920 @default.
• W3039269780 date "2020-09-01" @default.
• W3039269780 modified "2023-10-17" @default.
• W3039269780 title "Differences in Thromboembolic Complications Between Paroxysmal and Persistent Atrial Fibrillation Patients Following Electrical Cardioversion (From the ENSURE-AF Study)" @default.
• W3039269780 cites W1593729112 @default.
• W3039269780 cites W1979789863 @default.
• W3039269780 cites W2022779333 @default.
• W3039269780 cites W2059834495 @default.
• W3039269780 cites W2088103571 @default.
• W3039269780 cites W2121978604 @default.
• W3039269780 cites W2129301676 @default.
• W3039269780 cites W2140141379 @default.
• W3039269780 cites W2154658516 @default.
• W3039269780 cites W2163781421 @default.
• W3039269780 cites W2164861810 @default.
• W3039269780 cites W2295490840 @default.
• W3039269780 cites W2515488477 @default.
• W3039269780 cites W2517494398 @default.
• W3039269780 cites W2572955139 @default.
• W3039269780 cites W2598361327 @default.
• W3039269780 cites W2738999115 @default.
• W3039269780 cites W2740503577 @default.
• W3039269780 cites W2969756980 @default.
• W3039269780 cites W2979231018 @default.
• W3039269780 cites W2989627761 @default.
• W3039269780 cites W4232277679 @default.
• W3039269780 doi "https://doi.org/10.1016/j.amjcard.2020.06.046" @default.
• W3039269780 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32753268" @default.
• W3039269780 hasPublicationYear "2020" @default.
• W3039269780 type Work @default.
• W3039269780 sameAs 3039269780 @default.
• W3039269780 citedByCount "9" @default.
• W3039269780 countsByYear W30392697802020 @default.
• W3039269780 countsByYear W30392697802021 @default.
• W3039269780 countsByYear W30392697802022 @default.
• W3039269780 countsByYear W30392697802023 @default.
• W3039269780 crossrefType "journal-article" @default.
• W3039269780 hasAuthorship W3039269780A5011073019 @default.
• W3039269780 hasAuthorship W3039269780A5019955596 @default.
• W3039269780 hasAuthorship W3039269780A5029533765 @default.
• W3039269780 hasAuthorship W3039269780A5033166833 @default.
• W3039269780 hasAuthorship W3039269780A5038405190 @default.
• W3039269780 hasAuthorship W3039269780A5070415714 @default.
• W3039269780 hasAuthorship W3039269780A5082164920 @default.
• W3039269780 hasConcept C126322002 @default.
• W3039269780 hasConcept C127413603 @default.
• W3039269780 hasConcept C164705383 @default.
• W3039269780 hasConcept C168563851 @default.
• W3039269780 hasConcept C203092338 @default.
• W3039269780 hasConcept C2777289489 @default.
• W3039269780 hasConcept C2778198053 @default.
• W3039269780 hasConcept C2779161974 @default.
• W3039269780 hasConcept C2780645631 @default.
• W3039269780 hasConcept C2985986913 @default.
• W3039269780 hasConcept C500558357 @default.
• W3039269780 hasConcept C71924100 @default.
• W3039269780 hasConcept C78519656 @default.
• W3039269780 hasConceptScore W3039269780C126322002 @default.
• W3039269780 hasConceptScore W3039269780C127413603 @default.
• W3039269780 hasConceptScore W3039269780C164705383 @default.
• W3039269780 hasConceptScore W3039269780C168563851 @default.
• W3039269780 hasConceptScore W3039269780C203092338 @default.
• W3039269780 hasConceptScore W3039269780C2777289489 @default.
• W3039269780 hasConceptScore W3039269780C2778198053 @default.
• W3039269780 hasConceptScore W3039269780C2779161974 @default.
• W3039269780 hasConceptScore W3039269780C2780645631 @default.
• W3039269780 hasConceptScore W3039269780C2985986913 @default.
• W3039269780 hasConceptScore W3039269780C500558357 @default.
• W3039269780 hasConceptScore W3039269780C71924100 @default.
• W3039269780 hasConceptScore W3039269780C78519656 @default.
• W3039269780 hasLocation W30392697801 @default.
• W3039269780 hasLocation W30392697802 @default.
• W3039269780 hasOpenAccess W3039269780 @default.
• W3039269780 hasPrimaryLocation W30392697801 @default.
• W3039269780 hasRelatedWork W1864361583 @default.
• W3039269780 hasRelatedWork W1972651039 @default.
• W3039269780 hasRelatedWork W2063589187 @default.
• W3039269780 hasRelatedWork W2067977631 @default.
• W3039269780 hasRelatedWork W2073453392 @default.
• W3039269780 hasRelatedWork W2300086221 @default.
• W3039269780 hasRelatedWork W2317055961 @default.
• W3039269780 hasRelatedWork W2335083084 @default.
• W3039269780 hasRelatedWork W2981327070 @default.
• W3039269780 hasRelatedWork W3029306217 @default.
• W3039269780 hasVolume "131" @default.
• W3039269780 isParatext "false" @default.
• W3039269780 isRetracted "false" @default.
• W3039269780 magId "3039269780" @default.
• W3039269780 workType "article" @default.